Venous thromboembolism in breast cancer patients receiving cyclin‐dependent kinase inhibitors
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Venous thromboembolism in breast cancer patients receiving cyclin‐dependent kinase inhibitors
Authors
Keywords
-
Journal
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-09-04
DOI
10.1111/jth.14630
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer
- (2019) Alok A. Khorana et al. NEW ENGLAND JOURNAL OF MEDICINE
- Breast Cancer, Version 3.2018
- (2019) Matthew P. Goetz et al. Journal of the National Comprehensive Cancer Network
- Real-world clinical outcomes and toxicity in metastatic breast cancer patients treated with palbociclib and endocrine therapy
- (2019) Leticia Varella et al. BREAST CANCER RESEARCH AND TREATMENT
- Impact of palbociclib plus letrozole on patient-reported health-related quality of life: results from the PALOMA-2 trial
- (2018) H S Rugo et al. ANNALS OF ONCOLOGY
- 4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)†
- (2018) F Cardoso et al. ANNALS OF ONCOLOGY
- Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)
- (2018) Annie M. Young et al. JOURNAL OF CLINICAL ONCOLOGY
- Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial
- (2018) Debu Tripathy et al. LANCET ONCOLOGY
- Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
- (2018) Gary E. Raskob et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abemaciclib: The Newest CDK4/6 Inhibitor for the Treatment of Breast Cancer
- (2018) Alison Palumbo et al. ANNALS OF PHARMACOTHERAPY
- A Real-World Experience of Palbociclib-Induced Adverse Events and Compliance with Complete Blood Count (CBC) Monitoring in Women with Hormone Receptor (HR) -Positive/Her2-Negative Metastatic Breast Cancer
- (2018) G.A. Watson et al. Clinical Breast Cancer
- Resistance to endocrine therapy in breast cancer: molecular mechanisms and future goals
- (2018) Małgorzata Szostakowska et al. BREAST CANCER RESEARCH AND TREATMENT
- Apixaban to Prevent Venous Thromboembolism in Patients with Cancer
- (2018) Marc Carrier et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cyclin-Dependent Kinase Inhibitor–Associated Thromboembolism
- (2018) Sven R. Olson et al. JAMA Oncology
- MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2− Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy
- (2017) George W. Sledge et al. JOURNAL OF CLINICAL ONCOLOGY
- MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer
- (2017) Matthew P. Goetz et al. JOURNAL OF CLINICAL ONCOLOGY
- Risk Assessment Scores for Cancer-Associated Venous Thromboembolic Disease
- (2017) Dana Angelini et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Apixaban and dalteparin in active malignancy associated venous thromboembolism
- (2017) Charles Loprinzi et al. THROMBOSIS AND HAEMOSTASIS
- An unjustified benefit: immortal time bias in the analysis of time-dependent events
- (2017) Andreas Gleiss et al. TRANSPLANT INTERNATIONAL
- A Phase I Study of the Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib (LEE011) in Patients with Advanced Solid Tumors and Lymphomas
- (2016) J. R. Infante et al. CLINICAL CANCER RESEARCH
- Endocrine Therapy for Hormone Receptor–Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline
- (2016) Hope S. Rugo et al. JOURNAL OF CLINICAL ONCOLOGY
- Guidance for the prevention and treatment of cancer-associated venous thromboembolism
- (2016) Alok A. Khorana et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial
- (2016) Massimo Cristofanilli et al. LANCET ONCOLOGY
- Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer
- (2016) Gabriel N. Hortobagyi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Palbociclib and Letrozole in Advanced Breast Cancer
- (2016) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- The humanistic and economic burden of venous thromboembolism in cancer patients
- (2015) Georgia Kourlaba et al. BLOOD COAGULATION & FIBRINOLYSIS
- Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State
- (2015) Betsy A. Kohler et al. JNCI-Journal of the National Cancer Institute
- The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study
- (2015) Richard S Finn et al. LANCET ONCOLOGY
- Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State
- (2015) Betsy A. Kohler et al. JNCI-Journal of the National Cancer Institute
- Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine
- (2014) Lawrence M. Gelbert et al. INVESTIGATIONAL NEW DRUGS
- US Incidence of Breast Cancer Subtypes Defined by Joint Hormone Receptor and HER2 Status
- (2014) Nadia Howlader et al. JNCI-Journal of the National Cancer Institute
- Risk of venous and arterial thromboembolic events associated with anti-EGFR agents: a meta-analysis of randomized clinical trials
- (2012) F. Petrelli et al. ANNALS OF ONCOLOGY
- Development and validation of a predictive model for chemotherapy-associated thrombosis
- (2008) A. A. Khorana et al. BLOOD
- Risk stratification and venous thromboprophylaxis in hospitalized medical and cancer patients
- (2008) Paolo Prandoni et al. BRITISH JOURNAL OF HAEMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search